Skip to Main content Skip to Navigation
Journal articles

Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs

Abstract : Background: A major problem for diagnosing the antiphospholipid syndrome (APS) is the high variability between commercial anti-β2glycoprotein I (β2GPI) assays. Predominantly antibodies reactive against cryptic epitope Glycine40-Arginine43 (G40-R43) in domain I are associated with an increased risk for thrombosis. Upon interaction with anionic surfaces β2GPI opens up, thereby exposing G40-R43. Objectives: To examine whether suboptimal exposure of epitope G40-R43 explains the variations in results observed between commercial assays. Methods: Two patient-derived monoclonal antibodies were tested on neutral versus anionic plates. Antibody P1-117 reacts with G40-R43 in the open conformation while P2-6 recognizes β2GPI irrespective of its conformation. These antibodies were tested in commercial anti-β2GPI assays (A–E). Results: In assay A, both antibodies showed equal reactivity towards β2GPI, indicating that all the β2GPI exposes G40-R43. In other assays P1-117 displayed lower reactivity than P2-6, demonstrating reduced G40-R43 availability. To exclude influences of other assay features, reactivity was re-examined on plates of assay A and B using the protocol/reagents from each assay. In all combinations, reactivity of both antibodies on a plate was comparable to results obtained with its own protocol/reagents, suggesting that the coating, rather than other assay components, accounts for the observed differences. In two patient cohorts we demonstrated that a number of domain I-reactive samples are missed in assays characterized by a decreased exposure of epitope G40-R43. Conclusions: Exposure of epitope G40-R43 on β2GPI is highly variable between commercial anti-β2GPI assays. As a consequence, patients can be falsely assigned negative in assays characterized by a reduced exposure of G40-R43.
Complete list of metadata

Cited literature [20 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-01737762
Contributor : DCAC UL Connect in order to contact the contributor
Submitted on : Monday, March 19, 2018 - 5:39:48 PM
Last modification on : Tuesday, October 13, 2020 - 10:46:32 AM
Long-term archiving on: : Tuesday, September 11, 2018 - 8:36:53 AM

File

journal.pone.0071402.PDF
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Leonie Pelkmans, Hilde Kelchtermans, Philip G de Groot, Stéphane Zuily, Véronique Regnault, et al.. Variability in Exposure of Epitope G40-R43 of Domain I in Commercial Anti-Beta2-Glycoprotein I IgG ELISAs. PLoS ONE, Public Library of Science, 2013, 8 (8), pp.e71402. ⟨10.1371/journal.pone.0071402⟩. ⟨hal-01737762⟩

Share

Metrics

Record views

71

Files downloads

117